AltruBio
CA - San FranciscoBiotechnology
Focus: AltruBio is a Series B antibody therapeutics biotech focused on oncology and inflammatory conditions, headquartered in San Francisco. The company is at the preclinical-to-early-clinical stage with a pipeline centered on immunomodulatory antibodies.
Profile data last refreshed 20h ago · AI intelligence enriched 2w ago
Funding Stage
SERIES B
Open Jobs
0
About AltruBio
AI assessmentNot HiringNo open roles listed right now. Follow AltruBio to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ALTB-268
Healthy VolunteersClinical Trials (1)
NCT05723692A First-In-Human SAD and MAD Study to Evaluate the Safety, Tolerability, PK and PD of SC Administered ALTB-268 in Healthy Volunteers
Phase 1Help build intelligence for AltruBio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.